IBS hospital launches brain mapping device, claims it is first of its kind

With combination of decades of research with cutting edge technology, IBS Hospitals today launched first brain mapping device connectomics/ quicktome in the country

BARC and Sree Chitra Tirunal Institute to jointly develop deep brain stimulator
Brain Mapping
Press Trust of India New Delhi
2 min read Last Updated : Aug 22 2022 | 7:08 AM IST

Combining research with cutting-edge technology, a Delhi-based hospital on Sunday launched a "brain mapping device" and claimed it was the first-of-its-kind gadget in the country.

With the advent of such personalised brain mapping, treatment for brain tumour and other brain surgeries have become much safer and due to the accuracy, damage to important brain areas can be avoided, it said in a statement.

"In a first-of-its-kind technology to be launched, with combination of decades of research with cutting edge technology, IBS Hospitals today launched first brain mapping device connectomics/ quicktome in the country," the private hospital claimed.

Quicktome uses sophisticated algorithms to analyse millions of data points and build a brain map personalised to each patient from a standard, non-invasive MRI scan. The maps, which doctors can view on their computers, offer a level of anatomical detail typically not available in a clinical setting, allowing surgeons to incorporate advanced brain network data into neurosurgical planning, it added.

"This pathbreaking technology is paving way to not only potentially treat a plethora of ailments pertaining to the brain functioning, pre and post operatively, but also to retrieve to its normal functioning," Dr Sachin Kandhari, neurosurgeon and managing director of the hospital was quoted as saying in the statement.

Established in 2011, IBS Hospitals specialise in advanced neurology, neurosurgery, spine surgery and joint replacement surgeries, according to its website.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :healthbrain tumourneurological disorders

First Published: Aug 22 2022 | 7:08 AM IST

Next Story